MedPath

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

Not Applicable
Completed
Conditions
Acute Renal Failure
Registration Number
NCT01819038
Lead Sponsor
Chulalongkorn University
Brief Summary

This research project is a prospective study to compare mortality between early renal replacement therapy (RRT) and late renal replacement therapy by using plasma neutrophil gelatinase associated lipocalin (pNGAL) as a tool in decision- making.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The patient must have given his/her informed and signed consent
  • patients with acute kidney injury in the intensive care ward.
Exclusion Criteria
  • The patient refuses to sign the consent
  • The patient is pregnant, parturient, or breastfeeding
  • End stage renal disease
  • Chronic renal failure
  • previous kidney transplant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
mortality rate28 day
Secondary Outcome Measures
NameTimeMethod
ventilator free-days28 days

Trial Locations

Locations (1)

King Chulalongkorn Memorial Hospital

🇹🇭

Bangkok, Thailand

King Chulalongkorn Memorial Hospital
🇹🇭Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.